Skip to content

Medicine Matters

Sharing successes, challenges and daily happenings in the Department of Medicine

Medicine Matters Home › Infectious Diseases › Page 4

Infectious Diseases

COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children

ARTICLE: COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children AUTHORS: Katerina Roznik, Jiashu Xue, Georgia Stavrakis, T Scott Johnston, Divya Kalluri, Rivka Ohsie, Caroline… Read More »COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children

The association of changes in depression severity after the onset of the COVID-19 pandemic and viral nonsuppression among people with HIV

ARTICLE: The association of changes in depression severity after the onset of the COVID-19 pandemic and viral nonsuppression among people with HIV AUTHORS: Tarfa Verinumbe, Catherine… Read More »The association of changes in depression severity after the onset of the COVID-19 pandemic and viral nonsuppression among people with HIV

Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester

ARTICLE: Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester AUTHORS: Amita Gupta, Michael D Hughes, Jorge Leon Cruz, Anchalee… Read More »Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester

Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection

ARTICLE: Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection AUTHORS: Nicole Frumento, Ariadne Sinnis-Bourozikas,… Read More »Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection